Attys Seek $29M In Fees After $105M Walgreens Deal

Attorneys representing investors in a suit claiming Walgreens touted overly rosy ​​financial projections in seeking shareholder approval of its plan to acquire a Swiss-based pharmacy chain operator have asked an Illinois...

Already a subscriber? Click here to view full article